FDA label
What is Tradjenta used for?
Tradjenta contains linagliptin. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Tradjenta?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Tradjenta, tablet, film coated
Indications and Usage, quoted from the label by Boehringer Ingelheim Pharmaceuticals, Inc. (NDA201280). Cross-references to other label sections are left out.
TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitations of Use
TRADJENTA is not recommended in patients with type 1 diabetes mellitus as it would not be effective.
TRADJENTA has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using TRADJENTA.
Source: DailyMed label, set id c797ea5c-cab7-494b-9044-27eba0cfe40f, version 32, effective March 21, 2025. NDC 0597-0140, one of 3 listings for this product.
Questions
What is Tradjenta used for?
The FDA label says: “TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.”
What drug class is Tradjenta?
FDA lists linagliptin in the Dipeptidyl Peptidase 4 Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.